norharman has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agim, ZS; Cannon, JR; Cruz-Hernandez, A; McCabe, GP; Montenegro, PC; Rochet, JC | 1 |
| Brittebo, EB; Fredriksson, A; Ostergren, A | 1 |
2 other study(ies) available for norharman and Nerve Degeneration
| Article | Year |
|---|---|
Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.
Topics: Amines; Animals; Carbolines; Dopaminergic Neurons; Dose-Response Relationship, Drug; Harmine; Heterocyclic Compounds, 3-Ring; Mesencephalon; Molecular Structure; Nerve Degeneration; Neurites; Neurons; Primary Cell Culture; Quinolines; Quinoxalines; Rats | 2018 |
Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Carbolines; Caspase 3; Caspases; Disease Models, Animal; Fluoresceins; Gait Disorders, Neurologic; Glial Fibrillary Acidic Protein; Gliosis; Harmine; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Nerve Degeneration; Neuroglia; Neurons; Neurotoxins; Organic Chemicals; Parkinsonian Disorders; PC12 Cells; Rats; Substantia Nigra | 2006 |